Global Non Therapeutic Biomolecules Market Size and Forecast 2024-2033| ABB Ltd., Schneider Electric SE, Eaton Corporation PLC, Larsen & Toubro Ltd., Siemens AG

The Non Therapeutic Biomolecules Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Non Therapeutic Biomolecules Market:

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

According to The Business Research Company’s Non Therapeutic Biomolecules Global Market Report 2024, The non-therapeutic biomolecules market size has grown rapidly in recent years. It will grow from $27.91 billion in 2023 to $31.11 billion in 2024 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increased research and development (r&d) investments, growing applications in research and diagnostics, rising awareness and adoption, strategic collaborations and partnerships, regulatory support

The non-therapeutic biomolecules market size is expected to see rapid growth in the next few years. It will grow to $47.21 billion in 2028 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to emerging market opportunities, advancements in data analytics and integration, growing focus on precision medicine, increasing investment in personalized healthcare, expanding application areas. Major trends in the forecast period include technological advancements, strategic collaborations, rising applications in agriculture, expanding role in industrial processes, customization and personalization.

The rapidly increasing number of research and laboratory testing is expected to propel the growth of the non-therapeutic biomolecules market going forward. Laboratory testing refers to the medical procedure that involves testing a sample of blood, urine, or other substance from the body to determine and monitoring of disease and draft a treatment plan, whereas research refers to the new knowledge is created or current knowledge is creatively applied to produce new concepts, theories, and understandings. Non-therapeutic biomolecules in laboratory testing are used to measure the presence or concentration of a biomarker molecule that indicates disease, to enhance the sensitivity and specificity of the test. For instance, according to the American Association for Clinical Chemistry (AACC), a US-based scientific and medical professional organization, more than 200,000 laboratories certified under the Clinical Laboratory Improvement Amendment (CLIA) execute almost 13 billion laboratory tests in the US each year, and laboratory services comprise 2.3% of U.S. healthcare expenditures and two percent of Medicare expenditures. Therefore, the rapidly increasing number of research and laboratory testing is driving the growth of the non-therapeutic biomolecules market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp

The non-therapeutic biomolecules market covered in this report is segmented –

1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies

2) By End User: Research, Pharma, In vitro diagnostics(IVD)

Product innovations are a key trend gaining popularity in the non-therapeutic biomolecules market. Major companies operating in the market are focused on research and development for product innovations to sustain their position in the market. For instance, in January 2022, BASF SE, a Germany-based multinational chemical company partnered with Caregen, a Korean-based company operating in biomimetic peptide research and development and introduced the Peptovitae series manufactured using liposome-encapsulation technology to expand its dermo-cosmetics portfolio to address a broad range of skin concerns with innovative and differentiated solutions. Liposomal encapsulation is a technique that uses fats to deliver essential vitamins or medications to specific body sections in tiny bubbles without affecting other body parts. The Peptovitae series addresses a wider range of skin concerns than are traditionally associated with the use of peptides such as signs of aging, enhancing the brightness of the skin, soothing skin prone to dryness and itching, and moisturizing skin.

The non therapeutic biomolecules market report table of contents includes:

1. Executive Summary

2. Non-Therapeutic Biomolecules Market Characteristics

3. Non-Therapeutic Biomolecules Market Trends And Strategies

4. Non-Therapeutic Biomolecules Market – Macro Economic Scenario

5. Global Non-Therapeutic Biomolecules Market Size and Growth

26. South America Non-Therapeutic Biomolecules Market

27. Brazil Non-Therapeutic Biomolecules Market

28. Middle East Non-Therapeutic Biomolecules Market

29. Africa Non-Therapeutic Biomolecules Market

30. Non-Therapeutic Biomolecules Market Competitive Landscape And Company Profiles

Top Major Players: